What is it about?
More patients with HCC are discovered in late stage with partial or branch portal vein invasion and well preserved liver functions may get benefits from TACE as palliative option
Featured Image
Why is it important?
In the limited resources countries the molecular targeted therapies are not affordable by many patients thus Searching for other modalities of treatment
Read the Original
This page is a summary of: Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis, Indian Journal of Gastroenterology, March 2018, Springer Science + Business Media,
DOI: 10.1007/s12664-018-0830-4.
You can read the full text:
Contributors
The following have contributed to this page
